Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) [Phase 2]
A Phase 2 trial is evaluating the combination of plinabulin and pegfilgrastim in people with multiple myeloma undergoing autologous stem cel…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults [Phase 4]
This Phase 4 trial assessed the humoral immune response to the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in immunocompromised adults compa…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM [Phase 2]
A Phase 2 trial update evaluating a quadruplet combination of isatuximab, lenalidomide, bortezomib, and dexamethasone for newly diagnosed mu…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
This Phase 1/2 trial evaluates the safety and activity of a carfilzomib, pomalidomide, and dexamethasone combination in adults with relapsed…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: ICOPE Program Feasibility in the Management of Myeloma Patients [NA]
A feasibility study evaluating the ICOPE program for managing frailty in patients with multiple myeloma. The study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
Real-world immunotherapy trial for Chinese patients with newly diagnosed multiple myeloma is currently recruiting. Sponsor is Peking Univers…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Selinexor and Backbone Treatments of Multiple Myeloma Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating selinexor with backbone therapies for multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]
This Phase 2 clinical trial is evaluating belantamab mafodotin in combination with carfilzomib, pomalidomide, and dexamethasone for relapsed…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning [Phase 2]
Phase 2 trial in multiple myeloma patients aged 65 or younger who have at least 50% response after autologous transplant is evaluating an al…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis [Phase 1]
This clinical trial update reports a Phase 1 study of romosozumab in women with osteoporosis and multiple myeloma, with the study currently …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
This document describes an EARLY_PHASE1 clinical trial evaluating LVIVO-TaVec200 for relapsed/refractory multiple myeloma, which is currentl…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Cevostamab Following CAR T Cell Therapy for RRMM [Phase 2]
This update reports on a Phase 2 clinical trial evaluating Cevostamab after CAR T cell therapy in relapsed or refractory multiple myeloma, c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma [Phase 1]
Phase 1 open-label trial of belantamab mafodotin in high-risk smoldering multiple myeloma is ongoing, with an extension cohort at a single c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse [Phase 2]
A Phase 2 trial evaluating subcutaneous talquetamab in elderly patients with early-relapse multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM [Phase 2]
This Phase 2 trial evaluates a four-drug regimen (lenalidomide, ixazomib, dexamethasone, and daratumumab) in transplant-ineligible patients …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD [Phase 1]
The FREEDMM trial is a Phase 1 study investigating whether patients with multiple myeloma can discontinue maintenance therapy based on minim…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial evaluating a triplet regimen of isatuximab, carfilzomib, and pomalidomide for relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluated stem cell transplantation with or without the growth factor tbo-filgrastim in patients with multiple myeloma or non-…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma [EARLY_Phase 1]
An early-phase clinical trial update exploring CAR-T cell therapy for multiple myeloma, with non-invasive monitoring of biodistribution usin…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of LCAR-B38M BCMA-directed CAR-T cells in Chinese participants with relapsed or refractory multiple myeloma has been termina…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. [Phase 2]
Phase II randomized trial evaluating cyclophosphamide and dexamethasone with ixazomib in relapsed or refractory multiple myeloma has complet…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients [Phase 3]
This document provides an update on a Phase 3 trial evaluating Motixafortide (BL-8040) with G-CSF for stem cell mobilization in multiple mye…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 clinical trial update evaluating belantamab mafodotin or daratumumab in combination with bortezomib, lenalidomide, and dexamethasone…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma [NA]
ClinicalTrials.gov reports the completion of a pilot rehabilitation intervention study for people living with multiple myeloma, with results…